PAS Research Services
7
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Role: collaborator
Healthcare Decisions on Dietary and Environmental Allergen Exposure
Role: collaborator
Increase Surveillance for Wellness Decisions, Also to Determine Targeted Risk-reducing and Preventative Strategies
Role: collaborator
Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
Role: collaborator
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Role: collaborator
Usage and Plan of Care Changes Due to Drug Screenings
Role: collaborator
How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
Role: collaborator
All 7 trials loaded